LANLUMA® V 210 mg – Collagen Stimulator for Facial Volume Restoration and Rejuvenation
LANLUMA® V 210 mg is an innovative injectable poly-L-lactic acid (PLLA) treatment developed by Sinclair Pharma for gradual facial volumization and collagen stimulation.
This next-generation bio-stimulator rejuvenates the skin from within, helping restore volume, elasticity, and a youthful structure through the body’s natural collagen production process.Unlike hyaluronic acid fillers, LANLUMA® V works progressively, providing subtle, natural improvements that enhance over time.
Product Overview
LANLUMA® V 210 mg is specifically formulated for facial rejuvenation and contouring, targeting areas affected by age-related volume loss and loss of firmness.
Its collagen-stimulating mechanism delivers results that evolve gradually, ensuring a balanced, natural aesthetic outcome that improves skin quality and density.
Technology
Advanced Poly-L-Lactic Acid (PLLA) Collagen Bio-Stimulation Technology
LANLUMA® V utilizes Sinclair’s optimized PLLA technology, designed to trigger controlled collagen regeneration for natural, long-term rejuvenation.
The unique structure and particle morphology of PLLA ensure smooth dispersion, predictable tissue response, and progressive restoration of volume and elasticity.
Key Technological Features:
Uniform PLLA Particle Size: Ensures even collagen induction and reduces the risk of nodules.
Controlled Bio-Stimulation: Stimulates fibroblasts to produce new Type I and Type III collagen, reinforcing skin density and firmness.
Hydrophilic Reconstitution System: Provides smooth suspension and consistent injection flow for reliable, even distribution.
Progressive Regeneration: Results improve over several months as new collagen forms, maintaining natural facial dynamics.
Composition
Poly-L-Lactic Acid (PLLA): 210 mg per vial
A biocompatible and biodegradable polymer that stimulates fibroblast activity to produce new collagen and elastin, improving firmness and structure.
Packaging
1 vial containing 210 mg of PLLA
Product labels
User instructions
Indications & Treatment Areas
Indications:
Facial volume restoration
Skin tightening and rejuvenation
Improvement of skin elasticity and firmness
Treatment Areas:
Cheeks: restores natural contour and projection
Jawline: enhances definition and structure
Temples: corrects hollowness and sagging
Nasolabial folds: reduces deep creases and improves skin smoothness
Marionette lines: lifts and refines the lower face
Chin: improves contour and projection
Clinical Benefits
Stimulates natural collagen production for long-term rejuvenation
Restores facial volume gradually and evenly
Improves skin tone and texture through bio-stimulation
Long-lasting results for up to 24 months
Safe and biocompatible formulation with proven clinical efficacy
Treatment Protocol
Initial Phase: 2–3 sessions spaced 4–6 weeks apart, depending on individual needs
Maintenance Phase: Results continue to improve progressively as new collagen forms over the following months
Injection Depth: Subcutaneous or deep dermal layers using a cannula or needle
Technique: Reconstitute according to manufacturer instructions before injection
Duration of Results
Results are gradual and cumulative, typically lasting 18–24 months, depending on skin type, metabolism, and treatment area.
Collagen production continues even after the initial sessions, offering progressive enhancement and a refreshed, youthful appearance.
Manufacturer & Regulatory Information
Manufactured by Sinclair Pharma (United Kingdom)
CE-marked Class III Medical Device under EU Regulation (MDR) 2017/745
ISO 13485 certified manufacturer
Distributed under compliance with AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) in Spain and the European Union
For Professional Use Only:
As trusted distributors and providers of aesthetic medicine, Aesthisave® emphasizes that our products are strictly for professional use.
We insist that these treatments be administered only by trained and medically qualified personnel, ensuring the highest standards of safety, precision, and patient care.
